228 related articles for article (PubMed ID: 30652303)
21. IL-37 alleviates alveolar bone resorption and inflammatory response through the NF-κB/NLRP3 signaling pathway in male mice with periodontitis.
Li L; Li J; Li S; Chen H; Wu Y; Qiu Y
Arch Oral Biol; 2023 Mar; 147():105629. PubMed ID: 36680836
[TBL] [Abstract][Full Text] [Related]
22. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
[TBL] [Abstract][Full Text] [Related]
23. Diaporisoindole E inhibits RANKL-induced osteoclastogenesis via suppression of PI3K/AKT and MAPK signal pathways.
Hua P; Cui H; Xu J; Cai R; She Z; Gu Q
Phytomedicine; 2020 Aug; 75():153234. PubMed ID: 32510335
[TBL] [Abstract][Full Text] [Related]
24. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.
Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B
Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638
[TBL] [Abstract][Full Text] [Related]
25. Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation.
Chen K; Yuan Y; Wang Z; Song D; Zhao J; Cao Z; Chen J; Guo Q; Chen L; Tickner J; Xu J
J Cell Physiol; 2019 May; 234(5):6477-6488. PubMed ID: 30341897
[TBL] [Abstract][Full Text] [Related]
26. Isoalantolactone inhibits RANKL-induced osteoclast formation via multiple signaling pathways.
Lu J; Kuang Z; Chen T; Ye C; Hou W; Tang L; Chen Y; He R
Int Immunopharmacol; 2020 Jul; 84():106550. PubMed ID: 32388216
[TBL] [Abstract][Full Text] [Related]
27. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
28. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
[TBL] [Abstract][Full Text] [Related]
30. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
31. Effects of IL-34 and anti-IL-34 neutralizing mAb on alveolar bone loss in a ligature-induced model of periodontitis.
Duarte C; Yamada C; Ngala B; Garcia C; Akkaoui J; Birsa M; Ho A; Nusbaum A; AlQallaf H; John V; Movila A
Mol Oral Microbiol; 2024 Jun; 39(3):93-102. PubMed ID: 37902168
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
33. PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo.
Zhou Z; Chen X; Chen X; Qin A; Mao Y; Pang Y; Yu S; Zhang S
Exp Cell Res; 2020 Mar; 388(2):111857. PubMed ID: 31972221
[TBL] [Abstract][Full Text] [Related]
34. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway.
Cui J; Li X; Wang S; Su Y; Chen X; Cao L; Zhi X; Qiu Z; Wang Y; Jiang H; Huang B; Ji F; Su J
J Cell Mol Med; 2020 Jun; 24(11):6149-6161. PubMed ID: 32347017
[TBL] [Abstract][Full Text] [Related]
35. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.
Song L; Tan J; Wang Z; Ding P; Tang Q; Xia M; Wei Y; Chen L
Mol Med Rep; 2019 Jun; 19(6):4743-4752. PubMed ID: 31059030
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity.
Yao J; Li J; Zhou L; Cheng J; Chim SM; Zhang G; Quinn JM; Tickner J; Zhao J; Xu J
J Cell Physiol; 2015 Jun; 230(6):1235-42. PubMed ID: 25363829
[TBL] [Abstract][Full Text] [Related]
37. Rubiadin-1-methyl ether from Morinda officinalis How. Inhibits osteoclastogenesis through blocking RANKL-induced NF-κB pathway.
He YQ; Zhang Q; Shen Y; Han T; Zhang QL; Zhang JH; Lin B; Song HT; Hsu HY; Qin LP; Xin HL; Zhang QY
Biochem Biophys Res Commun; 2018 Dec; 506(4):927-931. PubMed ID: 30392907
[TBL] [Abstract][Full Text] [Related]
38. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory Effects of Panduratin A on Periodontitis-Induced Inflammation and Osteoclastogenesis through Inhibition of MAPK Pathways In Vitro.
Kim H; Kim MB; Kim C; Hwang JK
J Microbiol Biotechnol; 2018 Feb; 28(2):190-198. PubMed ID: 29061028
[TBL] [Abstract][Full Text] [Related]
40. Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice.
Zhang Z; Song J; Kwon SH; Wang Z; Park SG; Piao X; Ryu JH; Kim N; Kim OS; Kim SH; Koh JT
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
